AVOBENZONE, HOMOSALATE, OCTOCRYLENE

N/A

Manufactured by CVS

123 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AVOBENZONE, HOMOSALATE, OCTOCRYLENE

AVOBENZONE, HOMOSALATE, OCTOCRYLENE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CVS. The most commonly reported adverse reactions for AVOBENZONE, HOMOSALATE, OCTOCRYLENE include HEADACHE, MALAISE, DYSPNOEA, INSOMNIA, ASTHENIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AVOBENZONE, HOMOSALATE, OCTOCRYLENE.

Top Adverse Reactions

HEADACHE5 reports
MALAISE5 reports
DYSPNOEA4 reports
INSOMNIA4 reports
ASTHENIA3 reports
COVID 193 reports
INCORRECT DOSE ADMINISTERED3 reports
NAUSEA3 reports
NIGHTMARE3 reports
OVERDOSE3 reports
ABDOMINAL DISCOMFORT2 reports
ABDOMINAL PAIN UPPER2 reports
ABNORMAL DREAMS2 reports
APPLICATION SITE BURN2 reports
APPLICATION SITE ERYTHEMA2 reports
APPLICATION SITE PAIN2 reports
BACK PAIN2 reports
DISEASE RECURRENCE2 reports
INCORRECT DRUG ADMINISTRATION DURATION2 reports
SLEEP DISORDER2 reports
TREATMENT NONCOMPLIANCE2 reports
VOMITING2 reports
AGEUSIA1 reports
AGORAPHOBIA1 reports
ANAL HAEMORRHAGE1 reports
ANXIETY1 reports
APPLICATION SITE HYPERSENSITIVITY1 reports
APPLICATION SITE PARAESTHESIA1 reports
APPLICATION SITE PRURITUS1 reports
APPLICATION SITE SWELLING1 reports
CATARACT OPERATION1 reports
CHILLS1 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE1 reports
COLD SWEAT1 reports
COMA1 reports
CONCOMITANT DISEASE AGGRAVATED1 reports
CONDITION AGGRAVATED1 reports
CONSTIPATION1 reports
COUGH1 reports
DECREASED APPETITE1 reports
DIARRHOEA1 reports
DYSPEPSIA1 reports
EUPHORIC MOOD1 reports
FALL1 reports
FATIGUE1 reports
FEELING ABNORMAL1 reports
FUNGAL INFECTION1 reports
GAIT DISTURBANCE1 reports
GASTRIC HAEMORRHAGE1 reports
GASTROINTESTINAL DISORDER1 reports
GASTROOESOPHAGEAL REFLUX DISEASE1 reports
GENERAL PHYSICAL HEALTH DETERIORATION1 reports
HUNGER1 reports
HYPERHIDROSIS1 reports
HYPERSENSITIVITY1 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION1 reports
INFLUENZA1 reports
IRRITABILITY1 reports
JOINT SWELLING1 reports
LOCAL SWELLING1 reports
LYME DISEASE1 reports
MANIA1 reports
MEMORY IMPAIRMENT1 reports
MOVEMENT DISORDER1 reports
MUSCULOSKELETAL DISCOMFORT1 reports
NASOPHARYNGITIS1 reports
OFF LABEL USE1 reports
OROPHARYNGEAL PAIN1 reports
PLEURISY1 reports
PNEUMONIA1 reports
POLYNEUROPATHY1 reports
POST TRAUMATIC STRESS DISORDER1 reports
PRODUCT ADHESION ISSUE1 reports
PYREXIA1 reports
RECTAL HAEMORRHAGE1 reports
RENAL FAILURE1 reports
RESTLESSNESS1 reports
SINUS DISORDER1 reports
SOMNAMBULISM1 reports
SOMNOLENCE1 reports
SPEECH DISORDER1 reports
SUNBURN1 reports
TRANSIENT ISCHAEMIC ATTACK1 reports
UPPER RESPIRATORY TRACT INFECTION1 reports
VISION BLURRED1 reports

Report Outcomes

Out of 29 classified reports for AVOBENZONE, HOMOSALATE, OCTOCRYLENE:

Serious 75.9%Non-Serious 24.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female16 (57.1%)
Male12 (42.9%)

Reports by Age

Age 372 reports
Age 492 reports
Age 572 reports
Age 51 reports
Age 211 reports
Age 261 reports
Age 441 reports
Age 481 reports
Age 511 reports
Age 521 reports
Age 541 reports
Age 601 reports
Age 631 reports
Age 641 reports
Age 651 reports
Age 661 reports
Age 681 reports
Age 721 reports
Age 731 reports
Age 761 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AVOBENZONE, HOMOSALATE, OCTOCRYLENE?

This profile reflects 123 FDA FAERS reports that mention AVOBENZONE, HOMOSALATE, OCTOCRYLENE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AVOBENZONE, HOMOSALATE, OCTOCRYLENE?

Frequently reported terms in FAERS include HEADACHE, MALAISE, DYSPNOEA, INSOMNIA, ASTHENIA, COVID-19. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AVOBENZONE, HOMOSALATE, OCTOCRYLENE?

Labeling and FAERS entries often list CVS in connection with AVOBENZONE, HOMOSALATE, OCTOCRYLENE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.